Reumatologia Clinica最新文献

{"title":"External validation of the 2017 ACR/EULAR classification criteria for inflammatory myopathies in a Mexican cohort: Role of autoantibodies in the diagnosis and classification of patients with inflammatory myopathies","authors":"Grisel Guadalupe Sánchez-Mendieta,&nbsp;David Vega-Morales,&nbsp;Miguel Ángel Villarreal-Alarcón,&nbsp;Jesús Eduardo Compean-Villegas,&nbsp;Ilse Andrea Moreno-Arquieta,&nbsp;Dionicio Ángel Galarza-Delgado","doi":"10.1016/j.reuma.2023.11.002","DOIUrl":"10.1016/j.reuma.2023.11.002","url":null,"abstract":"<div><h3>Objective</h3><p>This retrospective study aimed to perform the first external validation of the ACR/EULAR classification criteria for inflammatory myopathy (IIM) in a Mexican dynamic cohort where the patients were evaluated with clinical and laboratory values. As secondary objectives, we presented the clinical characteristics of the patients and included antibodies other than anti Jo1 to evaluate their impact on our population.</p></div><div><h3>Methodology</h3><p>This study included 70 patients with IIM and 70 patients with differential diagnoses of IIM, according to the absolute score of the classification criteria. We obtained sensitivity and specificity in the modality without biopsy, and as an exploratory analysis, we added other antibodies from the myositis extended panel. We analyzed the area under the curve (AUC) of three models: score without antibodies, with anti Jo1 and with any antibody.</p></div><div><h3>Results</h3><p>The ACR/EULAR criteria showed increased specificity and at least similar sensitivity to that of the original cohort (85% sensitivity and 92% specificity), with a cohort point of &gt;55%. When we classified patients into definite, probable, possible, and no IIM categories, by adding the extended myopathy panel, 6 of the 10 patients initially classified as “no IIM” changed their classification to “Probable IIM” and 4 to “Definite IIM”; of the 16 patients classified as “probable IIM,” 15 changed their classification to “Definite IIM.”</p></div><div><h3>Conclusion</h3><p>Considering the limitations of this study, we concluded that the 2017 EULAR/ACR criteria for IIM classification are sensitive and specific for classifying patients with IIM in the Mexican population. Additionally, the addition of antibodies other than anti-Jo1 may improve performance in certain populations.</p></div>","PeriodicalId":47115,"journal":{"name":"Reumatologia Clinica","volume":"20 3","pages":"Pages 142-146"},"PeriodicalIF":1.5,"publicationDate":"2023-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139021171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evento cardiovascular en una cohorte de pacientes con artritis reumatoide en Castilla-La Mancha, utilidad de la ecografía carotídea","authors":"Marco Aurelio Ramírez Huaranga ,&nbsp;David Velasco Sánchez ,&nbsp;Luis Ángel Calvo Pascual ,&nbsp;David Castro Corredor ,&nbsp;María Dolores Mínguez Sánchez ,&nbsp;Verónica Salas Manzanedo ,&nbsp;Eva Revuelta Evrard ,&nbsp;Rocío Arenal López ,&nbsp;Joaquín Anino Fernández ,&nbsp;Marina González Peñas ,&nbsp;Lourdes Martin de la Sierra López ,&nbsp;Laura María Jiménez Rodríguez ,&nbsp;Alberto López Menchero Mora ,&nbsp;Marcos Paulino Huertas","doi":"10.1016/j.reuma.2023.11.001","DOIUrl":"10.1016/j.reuma.2023.11.001","url":null,"abstract":"<div><p>Rheumatoid arthritis (RA) has a mortality rate 1.3–3 times higher than the general population, with cardiovascular mortality accounting for 40%–50% of cases. Currently, cardiovascular disease is considered an extra-articular manifestation of RA (OR: 1.5–4.0). Ultrasound measurement of the intima-media thickness (IMT) of the common carotid artery and the presence of atherosclerotic plaques is a non-invasive method and a surrogate marker of subclinical arteriosclerosis.</p></div><div><h3>Objective</h3><p>To determine if subclinical arteriosclerosis findings through carotid ultrasound can serve as a good predictor of cardiovascular events (CVE) development in a cohort of RA patients over a 10-year period.</p></div><div><h3>Methodology</h3><p>A cohort of RA patients seen in the rheumatology outpatient clinic of a hospital in Castilla-La Mancha in 2013 was evaluated. A prospective evaluation for the development of CVE over the following 10 years was conducted, and its correlation with previous ultrasound findings of IMT and atherosclerotic plaques was analyzed.</p></div><div><h3>Results</h3><p>Eight (24%) patients experienced a CVE. Three (9%) had heart failure, three (9%) had a stroke, and two (6%) experienced acute myocardial infarction. RA patients who developed a CVE had a higher IMT (0.97<!--> <!-->±<!--> <!-->0.08<!--> <!-->mm) compared to the RA patients without cardiovascular complications (0.74<!--> <!-->±<!--> <!-->0.15<!--> <!-->mm) (<em>P</em> <!-->=<!--> <!-->.003). The presence of IMT<!--> <!-->≥<!--> <!-->0.9<!--> <!-->mm and atherosclerotic plaques had a relative risk of 12.25 (<em>P</em> <!-->=<!--> <!-->.012) and 18.66 (<em>P</em> <!-->=<!--> <!-->.003), respectively, for the development of a CVE.</p></div><div><h3>Conclusions</h3><p>Carotid ultrasound in RA patients may allow for early detection of subclinical atherosclerosis before the development of CVE, with IMT<!--> <!-->≥<!--> <!-->0.9<!--> <!-->mm being the most closely associated finding with CVE, unaffected by age.</p></div>","PeriodicalId":47115,"journal":{"name":"Reumatologia Clinica","volume":"20 3","pages":"Pages 150-154"},"PeriodicalIF":1.5,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139019914","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Is the use of secukinumab after anti-TNF therapy greater than expected for the risk of developing inflammatory bowel disease?","authors":"Fatih Albayrak ,&nbsp;Mustafa Gür ,&nbsp;Ahmet Karataş ,&nbsp;Süleyman Serdar Koca ,&nbsp;Bünyamin Kısacık","doi":"10.1016/j.reuma.2023.11.004","DOIUrl":"10.1016/j.reuma.2023.11.004","url":null,"abstract":"<div><h3>Objective</h3><p>In this study, our objective was to present real-life data on the incidence of inflammatory bowel disease (IBD) among patients receiving secukinumab treatment.</p></div><div><h3>Methods</h3><p>The study consisted of 209 patients who had prior exposure to anti-tumor necrosis factor (TNF) or were biologically naive. Patients with a pre-existing history of IBD were excluded from the study.</p></div><div><h3>Results</h3><p>Of the 209 patients in the study, 176 (84.3%) had ankylosing spondylitis, while 33 (15.7%) had psoriatic arthritis. 112 (53.6%) patients had prior exposure to at least one anti-TNF treatment before initiating secukinumab. IBD developed in 10 (4.8%) of the 209 patients. The incidence of IBD among patients who initiated secukinumab as their first biologic agent was 1%. For patients who had previously received any anti-TNF treatment and subsequently transitioned to secukinumab, the incidence of IBD was 8% (<em>p</em> <!-->=<!--> <!-->0.018, odds ratio (OR): 8.38, 95% CI: 1.04–67.45). A mean of 3.67 months (±4.3) after anti-TNF use, whereas IBD symptoms developed in the biologically naive patient after 15 months.</p></div><div><h3>Conclusion</h3><p>Our study observed IBD incidence in 4.8% of patients using secukinumab. Patients who initiated secukinumab after previous anti-TNF treatment exhibited a significantly higher rate and risk of developing IBD. The onset of IBD occurred earlier in these patients (mean 3.67 months), whereas a single case of IBD showed a longer duration (15 months). Further studies with larger patient numbers are warranted to provide a more comprehensive understanding of our findings.</p></div>","PeriodicalId":47115,"journal":{"name":"Reumatologia Clinica","volume":"20 3","pages":"Pages 123-127"},"PeriodicalIF":1.5,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139017561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Patient-journey of fibromyalgia patients: A scoping review","authors":"Teresa Otón ,&nbsp;Loreto Carmona ,&nbsp;Javier Rivera","doi":"10.1016/j.reuma.2023.07.006","DOIUrl":"https://doi.org/10.1016/j.reuma.2023.07.006","url":null,"abstract":"<div><h3>Background</h3><p>Fibromyalgia (FM) is a chronic disease characterized by widespread pain. Although much is known about this disease, research has focused on diagnosis and treatment, leaving aside factors related to patient's experience and the relationship with healthcare system.</p></div><div><h3>Objectives</h3><p>The aim was to analyze the available evidence on the experience of FM patients from the first symptoms to diagnosis, treatment, and follow-up.</p></div><div><h3>Methods</h3><p>A scoping review was carried out. Medline and the Cochrane Library were searched for original studies or reviews dealing with FM and focusing on “patient journey”. Results were organized using a deductive classification of themes.</p></div><div><h3>Results</h3><p>Fifty-four articles were included in the qualitative synthesis. Five themes were identified: the patient journey, the challenge for the health systems, a complex doctor–patient relationship, the importance of the diagnosis, and the difficulty of standardizing the treatment.</p></div><div><h3>Conclusions</h3><p>This scoping review confirms the negative impact of FM on the patient, their social environment, and health systems. It is necessary to minimize the difficulties encountered throughout the diagnosis and follow-up of patients with FM.</p></div>","PeriodicalId":47115,"journal":{"name":"Reumatologia Clinica","volume":"20 2","pages":"Pages 96-103"},"PeriodicalIF":1.5,"publicationDate":"2023-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139473206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Enfermedad gonocócica diseminada en pediatría: reporte de caso y revisión de la literatura","authors":"Ana K. Leos-Leija,&nbsp;Rocío C. Calderón-Zamora,&nbsp;Ana V. Villarreal-Treviño,&nbsp;Fernando García-Rodríguez,&nbsp;Manuel E. de La O-Cavazos,&nbsp;Nadina E. Rubio-Pérez","doi":"10.1016/j.reuma.2023.06.006","DOIUrl":"10.1016/j.reuma.2023.06.006","url":null,"abstract":"<div><p>Hematogenous spread of <em>Neisseria gonorrhoeae</em>, a sexually transmitted pathogen, results in disseminated gonococcal disease (DGD), also known as arthritis-dermatitis syndrome, due to the development of skin lesions, tenosynovitis, and arthritis. The most frequently affected population is young adults. We describe the case of an adolescent female who acutely developed skin lesions, arthritis, tenosynovitis, and constitutional symptoms. The causal agent was identified by a culture of vaginal secretion and treated with ceftriaxone for 7 days with complete recovery. It is important to differentiate this clinical picture from other types of arthritis developed in adolescence.</p></div>","PeriodicalId":47115,"journal":{"name":"Reumatologia Clinica","volume":"20 1","pages":"Pages 43-44"},"PeriodicalIF":1.5,"publicationDate":"2023-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138618205","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Síndrome de VEXAS: manifestaciones clínicas, diagnóstico y tratamiento","authors":"Michelle Patricia Loeza-Uribe ,&nbsp;Andrea Hinojosa-Azaola ,&nbsp;Beatriz E. Sánchez-Hernández ,&nbsp;José C. Crispín ,&nbsp;Elia Apodaca-Chávez ,&nbsp;Marcela A. Ferrada ,&nbsp;Eduardo Martín-Nares","doi":"10.1016/j.reuma.2023.10.006","DOIUrl":"https://doi.org/10.1016/j.reuma.2023.10.006","url":null,"abstract":"<div><p>VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is an adult-onset autoinflammatory syndrome characterized by somatic mutations in the <em>UBA1</em> gene and is considered the prototype of hematoinflammatory diseases. Patients with VEXAS syndrome exhibit inflammatory and hematological manifestations that can lead to clinical diagnoses such as relapsing polychondritis, polyarteritis nodosa, Sweet syndrome, and myelodysplastic syndrome. Diagnosis requires bone marrow evaluation to identify cytoplasmic vacuoles in myeloid and erythroid precursors. However, genetic confirmation of mutations in <em>UBA1</em> is necessary. Treatment is challenging and often involves glucocorticoids and immunosuppressants with variable responses. Hypomethylating agents and allogenic haemopoietic stem cell transplant are considered promising therapies. Prognosis is influenced by genetic and clinical factors. The aim of this review is to provide an overview of the pathogenesis, clinical presentation, treatment, and prognosis of VEXAS syndrome for the Latin American medical community.</p></div>","PeriodicalId":47115,"journal":{"name":"Reumatologia Clinica","volume":"20 1","pages":"Pages 47-56"},"PeriodicalIF":1.5,"publicationDate":"2023-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138738931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"La artritis reumatoide de inicio en el anciano recibe terapias menos agresivas que la artritis reumatoide de inicio en el adulto en una cohorte argentina","authors":"Nicolás Pérez ,&nbsp;María de los Ángeles Gargiulo ,&nbsp;Marina Khoury ,&nbsp;Lorena Suárez ,&nbsp;María de los Ángeles Correa ,&nbsp;Mariana Pera ,&nbsp;Natali Saravia ,&nbsp;Graciela Gómez","doi":"10.1016/j.reuma.2023.10.004","DOIUrl":"10.1016/j.reuma.2023.10.004","url":null,"abstract":"<div><h3>Objectives</h3><p>When rheumatoid arthritis (RA) starts after the age of 60 it is called elderly-onset rheumatoid arthritis (EORA) and when it starts earlier, young-onset rheumatoid arthritis (YORA). There are few Latin American studies that compared both groups. The objective of the study was to evaluate differences in the clinical characteristics, evolution and treatment among patients with RA with onset before or after 60<!--> <!-->years of age.</p></div><div><h3>Materials and methods</h3><p>Observational study of patients with RA attended consecutively in four centers in Argentina. Sociodemographic data, comorbidities, clinical manifestations at diagnosis, presence of rheumatoid factor and/or anti-CCP (cyclic citrullinated peptide) and treatments received were collected. At the last visit, swollen and tender joints, assessment of disease activity by the patient and physician, the presence of radiographic erosions, and functional status using the HAQ-DI were recorded.</p></div><div><h3>Results</h3><p>Fifty-one patients from each group were analyzed. The EORA group had a significantly higher proportion of smokers (58.8% vs. 35.3%, <em>P</em> <!-->=<!--> <!-->.029), cardiovascular history (54.9% vs. 21.6%, <em>P</em> <!-->=<!--> <!-->.001), abrupt onset (49% vs. 29.4%, <em>P</em> <!-->=<!--> <!-->.034) or with symptoms similar to PMR (19.6% vs. 0%, <em>P</em> <!-->=<!--> <!-->.001). Lower methotrexate doses were used in the EORA group: 19<!--> <!-->mg (15-25) vs. 21.9<!--> <!-->mg (20-25) (<em>P</em> <!-->=<!--> <!-->.0036) and more frequently did not receive bDMARDs or tsDMARDs.</p></div><div><h3>Discussion and conclusions</h3><p>The benefits of intensive treatment in patients with RA have been described. In this study, the use of DMARDs in the EORA group was less intensive, suggesting that advanced age constitutes a barrier in the therapeutic choice.</p></div>","PeriodicalId":47115,"journal":{"name":"Reumatologia Clinica","volume":"20 3","pages":"Pages 136-141"},"PeriodicalIF":1.5,"publicationDate":"2023-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139296064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Tasas de promoción, repitencia y abandono en la Carrera de Especialistas en Reumatología en la Ciudad de Buenos Aires","authors":"Vanesa Laura Cosentino ,&nbsp;Gustavo Casado ,&nbsp;Carla Gobbi ,&nbsp;Anastasia Secco ,&nbsp;Félix Romanini ,&nbsp;Gustavo Citera ,&nbsp;Marcos Rosemffet ,&nbsp;Silvia Papasidero ,&nbsp;María Alejandra Medina ,&nbsp;Juan Manuel Bande ,&nbsp;Karen Roberts ,&nbsp;Alejandro Brigante ,&nbsp;Guillermo Pons Estel ,&nbsp;María Celina de la Vega ,&nbsp;Gabriel Sequeira ,&nbsp;Eduardo Mario Kerzberg","doi":"10.1016/j.reuma.2023.10.002","DOIUrl":"10.1016/j.reuma.2023.10.002","url":null,"abstract":"<div><h3>Objectives</h3><p>To evaluate the trajectory of students enrolled in the specialty training in rheumatology.</p></div><div><h3>Methods</h3><p>Retrospective analysis (2009-2016). Promotion, repetition, and dropout rates were determined. Analysis was performed to define variables associated with academic success.</p></div><div><h3>Results</h3><p>Out of 119 students, the actual promotion rate was 66.4%, 11.8% failed an exam (at least) and completed the course after the stipulated time, and the dropout rate was 7.6%.</p><p>Among residents, the promotion rate was 82.5% vs. 48.2% among the rest (<em>P</em> <!-->&lt;<!--> <!-->.001), the lagging students’ repetition rate was 3.2% vs. 21.4% among the rest (<em>P</em> <!-->=<!--> <!-->.005), and the dropout rate was 3.2% vs. 12.5% among the rest (<em>P</em> <!-->=<!--> <!-->.06). A higher average score in medical school increased the chances of success in the postgraduate programme (OR: 3.41; 95%<!--> <span>C</span>I: 2.0-6.4; <em>P</em> <!-->&lt;<!--> <!-->.001).</p></div><div><h3>Conclusions</h3><p>The residency was associated with higher rates of academic success in postgraduate studies. The average score in medical school can help identify students at risk of failure.</p></div>","PeriodicalId":47115,"journal":{"name":"Reumatologia Clinica","volume":"20 2","pages":"Pages 92-95"},"PeriodicalIF":1.5,"publicationDate":"2023-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135614091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The role of chest X-ray in the early diagnosis and staging of sarcoidosis: Is it really should be done?","authors":"Aysu Sinem Koc ,&nbsp;Güray Oncel ,&nbsp;Ozlem Ince ,&nbsp;Fidan Sever ,&nbsp;Senol Kobak","doi":"10.1016/j.reuma.2023.08.006","DOIUrl":"https://doi.org/10.1016/j.reuma.2023.08.006","url":null,"abstract":"<div><h3>Background</h3><p>Sarcoidosis is a chronic granulomatous disease characterized by non-caseating granuloma. The conventional chest X-ray (CXR) has important role in the diagnosis, staging and follow-up of disease. Computed tomography (CT) is a second-line imaging method used to determine the extent, complications and differential diagnosis of sarcoidosis.</p></div><div><h3>Objectives</h3><p>To determine the role of CXR in the early diagnosis and staging of sarcoidosis and to compare with CT imaging.</p></div><div><h3>Methods</h3><p>One hundred and nine sarcoidosis patients followed at a single center were included in the study. Demographic, radiological, and clinical data of 81 patients were obtained from a total of 109 patients, and the record data of these 81 patients were evaluated. Patients who could not be reached for all tests were excluded from the study. CXR and CT imaging taken at diagnosis were evaluated retrospectively independently from two radiologists and one rheumatologist.</p></div><div><h3>Results</h3><p>Among 109 patients, eighty-one patients CXR and CT imaging taken at the same center has been reached. Among 81 sarcoidosis patients 23 (28.4%) were male, 58 (71.6%) were female. The mean patients age was 46.4 years and the mean disease duration was 3.8 years. CXR is regarded as normal at diagnosis in 30 patients (37%), while all of these patients had findings consistent with sarcoidosis on CT imaging. CT imaging are more superior than CXR in the early diagnosis and staging of sarcoidosis (<em>p</em> <!-->=<!--> <!-->0.001). Also CT imaging is more superior for detection of disease extent and complications.</p></div><div><h3>Conclusions</h3><p>In this study, we observed that CT imaging outperforms CXR in terms of early detection and staging of sarcoidosis. The use of CT imaging is important for early diagnosis and staging of sarcoidosis. The low performance of CXR is a condition that requires the discussion of this method. Multicenter prospective study is needed in this regard.</p></div>","PeriodicalId":47115,"journal":{"name":"Reumatologia Clinica","volume":"19 10","pages":"Pages 560-564"},"PeriodicalIF":1.5,"publicationDate":"2023-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72284195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"El valor predictivo de la autoeficacia en la evolución de la artritis reumatoide y su relación con el dolor y la función","authors":"Raquel Cantero-Téllez ,&nbsp;Ana Martin Mateos ,&nbsp;César Cuesta García ,&nbsp;Leire Cruz Gambero ,&nbsp;Santiago Garcia Orza ,&nbsp;Kristin Valdes","doi":"10.1016/j.reuma.2023.02.007","DOIUrl":"https://doi.org/10.1016/j.reuma.2023.02.007","url":null,"abstract":"<div><h3>Background and objectives</h3><p>Rheumatoid arthritis (RA) primarily affects the upper limbs and can cause disturbances in the performance of daily activities. The main objective of this study was to establish the relationship between self-efficacy, pain intensity, and duration of symptoms in patients with RA and analyse how each influences functional disability, and to determine the predictive value of self-efficacy over the other variables.</p></div><div><h3>Methods</h3><p>Cross-sectional study with a sample of 117 women diagnosed with RA. The endpoints were the visual analogue scale (VAS), Quick-DASH questionnaire and the Spanish scale of self-efficacy in rheumatic diseases.</p></div><div><h3>Results</h3><p>The most significant model for function (R² <!-->=<!--> <!-->0.35) includes function and pain, therefore, there is a relationship between self-efficacy, pain intensity, and upper limb functionality.</p></div><div><h3>Discussion and conclusions</h3><p>Our results agree with previous studies where a relationship between self-efficacy and functional disability is established, as well as self-efficacy and its relationship with physical functions, demonstrating that a low level of self-efficacy implies a decrease in functionality; however, no variable is more predictive than another.</p></div>","PeriodicalId":47115,"journal":{"name":"Reumatologia Clinica","volume":"19 10","pages":"Pages 549-554"},"PeriodicalIF":1.5,"publicationDate":"2023-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72284214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}